JMP Securities Upgrades Enanta Pharmaceuticals (ENTA) to Market Outperform
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.30 +3.66%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
JMP Securities upgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from Market Perform to Market Outperform with a price target of $32.00.
For an analyst ratings summary and ratings history on Enanta Pharmaceuticals click here. For more ratings news on Enanta Pharmaceuticals click here.
Shares of Enanta Pharmaceuticals closed at $23.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Cochlear Ltd. (COH:AU) to Neutral
- Axis Capital Limited Upgrades Colgate-Palmolive India (CLGT:IN) to Add (2)
- CLSA Upgrades Carabao Group (BK:CBG) to Hold (3)
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
